Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miconazole Oil in Otomycosis
NCT03130738Phase 2Completed
- Start
- Apr 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of miconazole in otomycosis (3 arms). Primary endpoint: Primary Efficacy Endpoint at Day 22. Started Apr 2017; status: completed.
02
Drugs
miconazole
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT03130738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130738.